1Y Target$18.31Near-term target
5Y Target$25.64Compound horizon
10Y Target$37.69Long-dated conviction
FCF—TTM—FCF not applicable for this sector (bank / insurer / REIT) or data unavailable
Rev+59.0%TTM YoYARevenue +59.0% — hypergrowth, top decile
D/E0.76totalBD/E 0.76 — at market average, manageable · Total D/E computed from balance sheet (short-term + long-term debt + lease obligations) ÷ stockholders equity. More accurate than native field, which often uses long-term debt only.
P/E14.6xB+P/E 14.6 — at or below S&P median, reasonable
PEG0.25proxyAPEG 0.25 — exceptional; paying well under fair value for growth · PEG proxy: P/E ÷ revenue growth % (true PEG requires forward EPS estimates, not in Finnhub free tier).
Why now
Banking · market cap $32.3b. 18% off the 52-week high of $19.46. Revenue growing +59% — in hypergrowth territory. PEG 0.25 — paying under fair value for the growth rate.
Moat
Net margin 31% is exceptional — pricing-power territory rare outside premium software, branded staples, and specialty pharma. Financial moat — scale of deposit base / underwriting franchise plus regulatory capital advantages. The largest players compound book value through cycles that erase smaller competitors.
Risk
Regulatory capital risk — stricter capital requirements (CCAR, Basel) can force a dividend cut or a capital raise; the largest banks are most exposed because they're held to the tightest standards.
Horizon
1-3 yr $18.31 (structural (no analyst coverage)) — fundamentals + valuation re-rating. 5 yr $25.64 at ~10% CAGR — compounding case rests on the competitive position widening. 10 yr $37.69 if current growth sustains into durable earnings power.
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See
terms and
methodology for full disclosures.